Latest H5N1 clinical trials Stories
World Health Organization officials on Friday announced that one dose of the H1N1 swine flu vaccine is all that is needed to ensure immunity against the virus.
GAITHERSBURG, Md., Oct.
ROCKVILLE, Md. and MARLBOROUGH, Mass., Oct. 21 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) and Xcellerex, Inc.
ROCKVILLE, Md., Oct. 20 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that it has initiated a two-stage clinical study of its virus-like-particle (VLP) H1N1 influenza vaccine in Mexico in collaboration with Avimex Laboratories (Avimex) and GE Healthcare.
SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved use of the seasonal influenza vaccine Fluarix for children ages 3 years to 17 years.
SAYRE, Pa., Oct. 16 /PRNewswire-USNewswire/ -- The Sayre Area School District in Bradford County today became the first Pennsylvania school district to begin administering Novel H1N1 influenza vaccine to its student population, the Department of Health announced.
Veterinary scientists have made a discovery that promises to deliver a new approach to fast development of cheap vaccines that are effective in all mammals â€“ not just humans or another particular species.
French drugmaker Sanofi-Aventis announced Wednesday that children under the age of 10 may need to get vaccinated twice in order to be protected against the H1N1 swine flu.
SWIFTWATER, Pa., Oct. 14 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today an interim analysis of data from clinical trials of the U.S.
BOXMEER, Netherlands, Oct.
- A volcanic mudflow.